Implants

Alimera Announces Agreement with Jaeb Center for Health Research on Behalf of the DRCR Retina Network

ILUVIEN or faricimab (6.0 mg) injections versus observation will be studied for the prevention of visual acuity loss due to…

2 years ago

Sientra Receives Regulatory Approval to Market Breast Implants in Saudi Arabia

Saudi Food & Drug Authority approval propels Sientra international expansion into the GCC and Middle East regionSANTA BARBARA, Calif., Sept.…

2 years ago

Sight Sciences OMNI® Surgical System to Be Featured in Multiple Presentations at the 2022 European Society of Cataract and Refractive Surgery Annual Meeting

Compendium of clinical presentations includes studies with up to 3.5 years of patient follow-up and over 400 eyes treated in…

2 years ago

Ocuphire Announces Upcoming Presentations at European Forum 2022, Eyecelerator@AAO 2022 and the American Academy of Ophthalmology 2022 Annual Meeting

FARMINGTON HILLS, Mich., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused…

2 years ago

Surgalign Announces FDA 510(k) Clearance of the Cortera™ Spinal Fixation System – The Company’s New Flagship Posterior Fixation Platform

DEERFIELD, Ill., Aug. 24, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on…

2 years ago

Neocis’ Imageless YomiPlan Go Workflow Launches Commercially

MIAMI, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental implant surgery,…

2 years ago

Fennec Pharmaceuticals Closes First $5 Million Investment From Petrichor

~ Under the Terms of the Investment Agreement, $5 Million to be Funded on initial closing and $20 Million to…

2 years ago

SeaSpine to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

CARLSBAD, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on…

2 years ago

Sight Sciences Announces Long-Term Safety and Effectiveness Data of Standalone Use of the OMNI® Surgical System in Patients with Open Angle Glaucoma

Three-year, standalone (not combined with cataract surgery) data shows the non-implantable minimally invasive glaucoma surgery effectively reduces intraocular pressure and…

2 years ago

CERiS White Paper Highlights Advantages of Pre-Payment Claims Review

Company is Leader in Payment Integrity Solutions FORT WORTH, Texas, Aug. 16, 2022 (GLOBE NEWSWIRE) -- CERiS, a CorVel company,…

2 years ago